Lataa...
Potential Role of CD47-Directed Bispecific Antibodies in Cancer Immunotherapy
The prosperity of immunological therapy for cancer has aroused enormous passion for exploiting the novel targets of cancer immunotherapy. After the approval of blinatumomab, a bispecific antibody (bsAb) targeting on CD19 for acute lymphoblastic leukemia, a few of CD47-targeted bsAbs for cancer immun...
Tallennettuna:
| Julkaisussa: | Front Immunol |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Frontiers Media S.A.
2021
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8297387/ https://ncbi.nlm.nih.gov/pubmed/34305918 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2021.686031 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|